Purchases and Sales Made in Q1 2024 in Evoke Pharma Inc (EVOK)
This table provides information about the institutional ownership of Evoke Pharma Inc (EVOK) during Q1 2024. The information is specifically focused on institutions that hold shares of Evoke Pharma Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2024
Q1 2024
|
Aigh Capital Management LLC
Baltimore, MD |
BUY
|
- |
847KNew |
$499K - $906K
|
847K
$398K
|
|
|
May 14, 2024
Q1 2024
|
Bleichroeder LP
New York, NY |
BUY
|
- |
825KNew |
$487K - $883K
|
825K
$388K
|
|
|
May 15, 2024
Q1 2024
|
Altium Capital Management LP
New York, NY |
BUY
|
- |
725KNew |
$428K - $776K
|
725K
$341K
|
|
|
May 15, 2024
Q1 2024
|
Nantahala Capital Management, LLC
New Canaan, CT |
BUY
|
- |
675KNew |
$398K - $722K
|
675K
$317K
|
|
|
May 15, 2024
Q1 2024
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
13.5KNew |
$7.95K - $14.4K
|
13.5K
$6.33K
|
|
|
May 15, 2024
Q1 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
10.9KNew |
$6.41K - $11.6K
|
10.9K
$5.11K
|
|
|
May 15, 2024
Q1 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
959+ 14.88% |
$566 - $1.03K
|
7.41K
$3.48K
|
|
|
May 10, 2024
Q1 2024
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
40+ 153.85% |
$23.6 - $42.8
|
66
$31
|
|
|
Apr 30, 2024
Q1 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-9- 0.61% |
$5.31 - $9.63
|
1.46K
$688
|
|
|
May 13, 2024
Q1 2024
|
Ubs Group Ag
|
SELL
|
- |
-1.81K- 62.01% |
$1.07K - $1.93K
|
1.11K
$520
|